EP1357111A1 — Pyridone derivative having affinity for cannabinoid 2-type receptor
Assigned to Shionogi and Co Ltd · Expires 2003-10-29 · 23y expired
What this patent protects
It was found that the compound having a binding activity to the cannabinoid type 2 receptor represented by the formula (I): wherein R' is a group represented by the formula: -Y 1 -Y 2 -Y 3 R a wherein Y 1 is single bond or the like; Y 2 is -C(=O)-NH- or the like; Y 3 is opt…
USPTO Abstract
It was found that the compound having a binding activity to the cannabinoid type 2 receptor represented by the formula (I): wherein R' is a group represented by the formula: -Y 1 -Y 2 -Y 3 R a wherein Y 1 is single bond or the like; Y 2 is -C(=O)-NH- or the like; Y 3 is optionally substituted aryl or the like; R 2 is hydrogen or the like; R 3 is alkyl or the like; R 4 is alkyl or the like; R 5 is optionally substituted alkyl or the like; or R 3 and R 4 taken together with the adjacent atom form cyclic group or the like.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.